Outcome of AGM
Bliss GVS Pharma Ltd has informed BSE that the members at the 26th Annual General meeting (AGM) of theCompany held on July 29, 2011, have;1. Approved the Audited Accounts & P&L; accounts for the year ended March 31, 2011, the Balance Sheet as at that date and the Reports of the Directors and Auditors.2. Appointed Mr. G. G. Desai as the director of the Company who was liable to retire by rotation.... Financial Results for June 30, 2011
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended June 30, 2011. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has informed BSE that Mr. Gautam R. Ashra has purchased 2,27,924 equity shares of the Company.Bliss GVS Pharma Ltd has also submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: Fixes Book Closure for Dividend & AGM
Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 18, 2011 to July 22, 2011 (both days inclusive) for the purpose of Payment of Dividend & 26th Annual General Meeting (AGM) of the Company to be held on July 29, 2011. Board recommends Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, approved:1. Appointment of Mr. Mayak Mehta as Independent Director of the Company.2. Recommendation of 30% Dividend i.e. Rs. 0.30 per equity share for the year ended March 31, 2011. Financial Results for Mar 31, 2011
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Period ended March 31, 2011. Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2011, inter alia, to consider the Audited Financial Result for the year ended March 31, 2011 and dividend if any. Resignation of Director
Bliss GVS Pharma Ltd has informed BSE that Mr. Yogendra N Thakkar is tended his resignation as an Independent Director of the Company on April 21, 2011 due to his personal reasons.